XML 60 R33.htm IDEA: XBRL DOCUMENT v3.25.1
Stockholders' Equity (Tables)
12 Months Ended
Dec. 31, 2024
Share-Based Payment Arrangement [Abstract]  
Schedule of Stock Options Activity
The following table summarizes stock option activity under the Company’s stock plans and related information:
(In thousands, except exercise prices and years)Options
Outstanding
Weighted-
Average
Exercise
Price
Weighted-
Average
Remaining Contract
Life (in years)
Aggregate
Intrinsic Value (a)
Balance at December 31, 20232,303 $48.70 6.8$99 
Granted1,971 10.39 
Exercised(15)9.97 
Canceled/forfeited(350)50.28 
Balance at December 31, 20243,909 $29.39 8.1$— 
Vested and expected to vest as of December 31, 20243,909 $29.39 8.1$— 
Exercisable at December 31, 20241,504 $58.95 6.5$— 
(a)The aggregate intrinsic value is calculated as the difference between the stock option exercise price and the closing price of the Company’s common stock as quoted on a national exchange.
Schedule of Fair Value of Option Issued Valuation Assumptions
The fair value of each stock option issued was estimated at the date of grant using the Black-Scholes valuation model with the following weighted-average assumptions:
OptionsEmployee Stock Purchase Plan
Years ended December 31,Years ended December 31,
2024202320242023
Expected volatility95%90%83%78%
Expected term (in years)6.06.01.31.3
Expected dividend yield
Risk-free interest rate3.9%4.2%4.3%5.0%
Schedule of Restricted Stock Units Activity
The following table summarizes the RSU activity under the Company’s stock plans and related information:
(In thousands, except grant date fair value and years)Number of
Units
Weighted-
Average
Grant Date
Fair Value
Weighted-
Average
Remaining
Contractual Term
(in years)
Balance at December 31, 2023154 21.73 1.4
Granted160 12.04 
Vested and released(29)26.20 
Forfeited(26)14.22 
Balance at December 31, 2024259 $16.00 1.2
Schedule of Stock-based Compensation Expense
The following table presents the Company’s stock-based compensation expense:
Years ended December 31,
20242023
(In thousands)
Research and development$4,544 $4,969 
General and administrative9,806 12,600 
Total share-based compensation expense$14,350 $17,569